"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials

被引：0

作者：

Fatola, Omolayo ^{[1
]}

Corneli, Amy ^{[2
,3
]}

Perry, Brian ^{[2
]}

Hanlen-Rosado, Emily ^{[2
]}

Nsonwu, Adora ^{[2
]}

Constantine, Evangelia P. ^{[4
]}

Thompson, Amelia B. ^{[5
,6
,7
]}

机构：

[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[2] Duke Univ, Dept Populat Hlth Sci, Sch Med, Durham, NC USA

[3] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC USA

[4] Dartmouth Coll, Hanover, NH 03755 USA

[5] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC USA

[6] Duke Univ, Dept Pediat, Div Infect Dis, Sch Med, Durham, NC USA

[7] AdventHlth Children, Div Infect Dis, Dept Pediat, Orlando, FL 32803 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2022年 / 11卷 / 05期

关键词：

adolescent; HIV; prevention; vaccine; VISP;

D O I：

10.1093/jpids/piac001

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States. Addressing adolescents' and their caregivers' concerns about vaccine-induced seropositivity will likely be essential to the success of future pediatric HIV vaccine trials in the United States.

引用

页码：221 / 224

页数：4

共 50 条

[21] Vaccine-induced autoimmunity
Cohen, AD
Shoenfeld, Y
JOURNAL OF AUTOIMMUNITY, 1996, 9 (06) : 699 - 703
[22] Vaccine-induced clotting
Devi, Sharmila
LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 29 - 29
[23] Reaction to measles vaccine/vaccine-induced measles
Groffik, A.
Bode, C.
Reifenberger, J.
HAUTARZT, 2008, 59 (10): : 766 - +
[24] Transience of vaccine-induced HIV-1-specific CTL and definition of vaccine "response"
Jamieson, BD
Ibarrondo, FJ
Wong, JT
Hausner, MA
Ng, HL
Fuerst, M
Price, C
Shih, R
Elliott, J
Hultin, PM
Hultin, LE
Anton, PA
Yang, OO
VACCINE, 2006, 24 (17) : 3426 - 3431
[25] A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials
Ehrenberg, Philip K.
Shangguan, Shida
Issac, Biju
Alter, Galit
Geretz, Aviva
Izumi, Taisuke
Bryant, Christopher
Eller, Michael A.
Wegmann, Frank
Apps, Richard
Creegan, Matthew
Bolton, Diane L.
Sekaly, Rafick P.
Robb, Merlin L.
Gramzinski, Robert A.
Pau, Maria G.
Schuitemaker, Hanneke
Barouch, Dan H.
Michael, Nelson L.
Thomas, Rasmi
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (507)
[26] Prophylactic HIV vaccine: vaccine regimens in clinical trials and potential challenges
Pitisuttithum, Punnee
Marovich, Mary Anne
EXPERT REVIEW OF VACCINES, 2020, 19 (02) : 133 - 142
[27] Vaccine-Induced Antibodies: Impact for HIV Diagnosis, Clinical Trial Participants and Public Health
Zinszner, H.
Voronin, Y.
Allen, M.
Busch, M.
Fruth, U.
Golding, H.
Khurana, S.
Mulenga, J.
Peel, S.
Schito, M.
Fast, P.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A182 - A182
[28] Vaccine-induced seropositivity (VISP) following immunization of healthy individuals with HIV DNA and recombinant modified vaccinia virus Ankara
Brave, A.
Nilsson, C.
Biberfeld, G.
Earl, P.
Gudmundsdotter, L.
Hejdeman, B.
Marovich, M.
Michael, N.
Moss, B.
Petterson, S.
Polonis, V.
Robb, M.
Sandstrom, E.
Wahren, B.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A11 - A11
[29] HIV VACCINE APPROVED FOR CLINICAL-TRIALS
MERZ, B
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (11): : 1433 - 1434
[30] Continuing Clinical Trials for HIV Vaccine Research
Gray, Glenda
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 104 - 104

← 1 2 3 4 5 →